Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer (BOND)

This study has been terminated.
(Change in study design)
Sponsor:
Information provided by (Responsible Party):
Cold Genesys, Inc.
ClinicalTrials.gov Identifier:
NCT01438112
First received: September 19, 2011
Last updated: July 27, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: November 2018 (Final data collection date for primary outcome measure)